Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear ribonucleoprotein polypeptide C pseudogene 3 (SNRPCP3) is a **human pseudogene**, meaning it is a nonfunctional segment of DNA that is similar in sequence to the functional SNRPC gene but does not encode a functional protein[4][5][6]. Pseudogenes are generally not transcribed or translated and lack biological function typical of enzymes, receptors, or regulatory proteins, though in rare cases other pseudogenes may exercise regulatory roles at the RNA level[3]. There is currently no evidence that SNRPCP3 is involved in normal cellular regulation or human disease, and it is not considered a drug target, biomarker, or a molecular target in therapeutic development[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide C pseudogene 3 (SNRPCP3).